Concepedia

Catherine Overed-Sayer

CO

Statistics

Publications

6

Citations

231

H-Index

6

Active since

2020

Affiliations

AstraZeneca (United Kingdom)(Current)

AstraZeneca (Sweden)

Cedars-Sinai Medical Center

AstraZeneca (Singapore)

Catherine Overed-Sayer is an author at AstraZeneca (United Kingdom) specializing in lung fibrosis, fibrosis, and pulmonary fibrosis progression.

ORCID

Publications per year

2020–2023

6

Publications

6

Increased expression and accumulation of GDF15 in IPF extracellular matrix contribute to fibrosis

Agata Radwańska, Christopher T. Cottage, Antonio Piras et al. · JCI Insight · 2022 · 65 citations · Full text

, , +17

De novo design of highly selective miniprotein inhibitors of integrins αvβ6 and αvβ8

Anindya Roy, Lei Shi, Ashley Chang et al. · Nature Communications · 2023 · 45 citations · Full text

, , +16

Inhibition of mast cells: a novel mechanism by which nintedanib may elicit anti-fibrotic effects

Catherine Overed-Sayer, Elena Miranda, Rebecca Dunmore et al. · Thorax · 2020 · 38 citations · Full text

, , +17

Epithelial senescence in idiopathic pulmonary fibrosis is propagated by small extracellular vesicles

Sabha Asghar, Susan J. Monkley, D Smith et al. · Respiratory Research · 2023 · 29 citations · Full text

, , +16

Sensitization of the UPR by loss of PPP1R15A promotes fibrosis and senescence in IPF

Susan J. Monkley, Catherine Overed-Sayer, Helen Parfrey et al. · Scientific Reports · 2021 · 27 citations · Full text

, , +13

1–5 of 6